1. Home
  2. BIO vs FOUR Comparison

BIO vs FOUR Comparison

Compare BIO & FOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • FOUR
  • Stock Information
  • Founded
  • BIO 1952
  • FOUR 1999
  • Country
  • BIO United States
  • FOUR United States
  • Employees
  • BIO N/A
  • FOUR N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • FOUR Business Services
  • Sector
  • BIO Industrials
  • FOUR Consumer Discretionary
  • Exchange
  • BIO Nasdaq
  • FOUR Nasdaq
  • Market Cap
  • BIO 6.0B
  • FOUR 6.3B
  • IPO Year
  • BIO N/A
  • FOUR 2020
  • Fundamental
  • Price
  • BIO $243.98
  • FOUR $98.81
  • Analyst Decision
  • BIO Strong Buy
  • FOUR Buy
  • Analyst Count
  • BIO 4
  • FOUR 21
  • Target Price
  • BIO $324.25
  • FOUR $113.37
  • AVG Volume (30 Days)
  • BIO 417.7K
  • FOUR 1.3M
  • Earning Date
  • BIO 07-31-2025
  • FOUR 08-07-2025
  • Dividend Yield
  • BIO N/A
  • FOUR N/A
  • EPS Growth
  • BIO N/A
  • FOUR 99.89
  • EPS
  • BIO N/A
  • FOUR 2.82
  • Revenue
  • BIO $2,541,100,000.00
  • FOUR $3,471,500,000.00
  • Revenue This Year
  • BIO N/A
  • FOUR $23.49
  • Revenue Next Year
  • BIO $3.49
  • FOUR $20.98
  • P/E Ratio
  • BIO N/A
  • FOUR $35.18
  • Revenue Growth
  • BIO N/A
  • FOUR 27.39
  • 52 Week Low
  • BIO $211.43
  • FOUR $57.45
  • 52 Week High
  • BIO $387.99
  • FOUR $127.50
  • Technical
  • Relative Strength Index (RSI)
  • BIO 60.94
  • FOUR 64.35
  • Support Level
  • BIO $235.01
  • FOUR $91.07
  • Resistance Level
  • BIO $246.50
  • FOUR $98.12
  • Average True Range (ATR)
  • BIO 7.17
  • FOUR 2.73
  • MACD
  • BIO 2.32
  • FOUR 0.18
  • Stochastic Oscillator
  • BIO 90.49
  • FOUR 90.62

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About FOUR Shift4 Payments Inc.

Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.

Share on Social Networks: